Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2005
11/30/2005EP1151108B1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
11/30/2005EP1078063B1 Basb029 polynucleotides and polypeptides from neisseria meningitis
11/30/2005EP1003853B1 Methods for protein screening
11/30/2005EP0870828B1 Novel polypeptide originating from hemophilus paragallinarum and process for producing the same
11/30/2005EP0808364B1 Human pancreatic cell lines: developments and uses
11/30/2005EP0797666B1 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase
11/30/2005CN1703518A Method of purifying lantibiotics
11/30/2005CN1703427A Methods and compositions to generate and control the effector profile of T cells by simultaneous loading and activation of selected subsets of antigen presenting cells
11/30/2005CN1703247A Anti-neovasculature preparations for cancer
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229499C Phosphodiesterase 8A
11/30/2005CN1229390C Peptides that lower blood glucose levels
11/30/2005CN1229387C Novel human protein with cancer-suppressing function and coding sequence thereof
11/30/2005CN1229386C Novel human protein with function for suppressing cancer and coding sequence thereof
11/30/2005CN1229385C Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/30/2005CN1229031C Improved bioactive whey protein hydrolysate
11/29/2005US6969760 Jak kinases and regulation of cytokine signal transduction
11/29/2005US6969599 Nucleic acids encoding tumor necrosis factor receptor TR10
11/29/2005US6969597 Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
11/29/2005CA2118329C Isolation, characterization, and use of the human .beta. subunit of the high affinity receptor for immunoglobulin e
11/24/2005WO2005111226A2 Characterization of mcra subunits and uses thereof
11/24/2005WO2005111225A1 O-linked glycoforms of polypeptides and method to manufacture them
11/24/2005WO2005111222A1 Method for expressing biosynthetic pathways and uses thereof
11/24/2005WO2005111213A1 Target gene mimitin of myc
11/24/2005WO2005111208A1 Method of proliferating plasma cell
11/24/2005WO2005111081A2 Immunoglobulin-like variable chain binding polypeptides and methods of use
11/24/2005WO2005111074A1 Modified coagulation factors with enhanced stability and their derivatives
11/24/2005WO2005111068A2 A method for purifying and recovering silk proteins using magnetic affinity separation
11/24/2005WO2005111060A2 Molecules involved in protein folding and methods op identifying them
11/24/2005WO2005079267A3 Methods for protein production
11/24/2005WO2005065239A3 Novel recombinant proteins with n-terminal free thiol
11/24/2005WO2005049852A3 Methods and compositions for inducing apoptosis
11/24/2005WO2005049795A3 Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide-mediated chromosomal sequence alteration
11/24/2005WO2005047511A3 Bacterial expression of protease inhibitors and variants thereof
11/24/2005WO2005046710A3 Tgf-beta binding and supported peptides
11/24/2005WO2005046709A3 Tgf - beta binding and supported peptides
11/24/2005WO2005033132A3 Igf binding proteins
11/24/2005WO2004092391A3 Metabolic engineering for enhanced production of chitin and chitosan in microorganisms
11/24/2005US20050261489 Immune system disorders, cancer, viral diseases
11/24/2005US20050261480 Super humanized antibodies
11/24/2005US20050261479 Method for purifying and recovering silk proteins using magnetic affinity separation
11/24/2005US20050261477 Pharmaceutical compositions and medical treatments comprising notch ligand proteins
11/24/2005US20050261193 Antimicrobial theta defensins and methods of using same
11/24/2005US20050261192 Novel polypeptide and its DNA
11/24/2005US20050261175 monoclonal antibody immunoreactive with a stem cell factor; hybridoma cell line; can stimulate growth of primitive progenitors including early hematopoietic progenitor cells
11/24/2005US20050260731 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
11/24/2005US20050260729 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
11/24/2005US20050260716 Non-immunoglobulin polypeptide, linker and dimerizing domain; cell-surface receptors; signal transduction
11/24/2005US20050260715 Efficient methods for producing antimicrobial cationic peptides in host cells
11/24/2005US20050260712 Process for preparing dipeptidyl peptidase IV inhibitors and intermediates therefor
11/24/2005US20050260711 Modulating pH-sensitive binding using non-natural amino acids
11/24/2005US20050260710 Methods for producing recombinant polyclonal immunoglobulins
11/24/2005US20050260709 Lipin1 function
11/24/2005US20050260707 Corynebacterium glutamicum genes encoding metabolic pathway proteins
11/24/2005US20050260705 Methods and cells for expression of recombinant protein products under the transcriptional control of an inducible promoter
11/24/2005US20050260704 Novel thrombolytic enzyme and a process for its preparation
11/24/2005US20050260701 Method for enzymatic production of GLP-1 (7-36) amide peptides
11/24/2005US20050260674 Specific polypeptides, useful as nematocides
11/24/2005US20050260673 nematode-specific gene products that can serve as targets for inhibitory peptides and proteins (e.g., antibodies) and antiparasitic chemicals
11/24/2005US20050260670 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
11/24/2005US20050260669 Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease
11/24/2005US20050260668 Novel compounds
11/24/2005US20050260655 Rearrangement of nucleotide sequences; obtain nucleotide sequences, incubate with ligase, ligate, recover and analyze nucleotide sequence product; used to diversify proteins
11/24/2005US20050260650 Alternatively spliced isoforms of interleukin-4 receptor subunit alpha (IL-4Ralpha)
11/24/2005US20050260644 Cell signaling proteins
11/24/2005US20050260642 CNGH0011 polynucleotides, polypeptides, antibodies, and compositions, and methods of production and use
11/24/2005US20050260632 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/24/2005US20050260622 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/24/2005US20050260621 Immunoreactive 38-KDA ferric binding protein of ehrlichia canis and uses thereof
11/24/2005US20050260616 Nucleotide and protein sequences of Nogo genes and methods based thereon
11/24/2005US20050260588 In vivo ssdna expression vectors for altering gene expression
11/24/2005US20050260579 TGF-beta type receptor cDNAs encoded products
11/24/2005US20050260576 Recombinantly expressed and isolated human SCN1A polypeptide and a modified human SCN1A nucleic acid that encodes it; producing an antibody that specifically binds a sodium channel; detecting and/or identifying a sodium channel polypeptide; anticonvulsants, neuroprotective agents and analgesics
11/24/2005US20050260565 contacting in vitro a sample comprising chemokine 88C receptor with a putative ligand, detecting binding of the 88C receptor and the putative ligand; increase in 88C signal transduction activity indicates the ligand is an activator, a decreasein transduction activity indicates the ligand is an inhibitor
11/24/2005US20050260234 Anti-neovasculature preparations for cancer
11/24/2005US20050260220 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines
11/24/2005US20050260218 House dust mite allergen, Der f VII, and uses therefor
11/24/2005US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide
11/24/2005US20050260215 Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
11/24/2005US20050260207 Monoclonal antibody neutralising cathepsin b activity and uses thereof
11/24/2005US20050260198 Inhibition of factor B, the alternative complement pathway and methods related thereto
11/24/2005US20050260197 Receptor for Oncostatin M
11/24/2005US20050260194 Immunoglobulin chimeric monomer-dimer hybrids
11/24/2005US20050260191 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments
11/24/2005US20050260186 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant soluble neutral active Hyaluronidase Glycoproteins to enhance stability and serum pharmacokinetics over natural slaughterhouse enzymes; transgenic animals; dosage forms
11/24/2005US20050260182 obtained from endophytic Streptomycetes isolated from higher plants; biological activity against plant pathogensPythium ultimum, Phytophthora cinnamomi, Cryptococcus neoformans, Candida albicans; parasitic Plasmodium falciparum; bacterial pathogen, Streptococcus pneumoniae; breast epithelial cancer cell
11/24/2005US20050260154 G-CSF analog compositions and methods
11/24/2005US20050259281 Method, apparatus and computer program for transforming digital colour images
11/24/2005CA2565872A1 T-cell death-inducing epitopes
11/24/2005CA2565414A1 O-linked glycoforms of polypeptides and method to manufacture them
11/23/2005EP1598425A1 Modified Vaccinia Ankara virus variant
11/23/2005EP1598419A1 Monoclonal antibody, gene encoding the same, hybridoma, medicinal composition and diagnostic reagent
11/23/2005EP1598369A1 Antibody and use thereof
11/23/2005EP1598368A1 Anti-pci neutralizing antibody
11/23/2005EP1598367A1 Modified coagulation factors with enhanced stability and their derivatives
11/23/2005EP1598362A2 Chlamidya trachomatis antigens
11/23/2005EP1597382A2 Genetically modified non-human mammals and cells
11/23/2005EP1597381A2 Production of modified glycoproteins having multiple antennary structures
11/23/2005EP1597380A2 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
11/23/2005EP1597379A2 Endomannosidases in the modification of glycoproteins in eukaryotes
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 1125